Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Molecular hydrogen treatment improves cognitive problems in Alzheimer’s model

Mariane Cristine Vicente, Arthur Dalmolin Dahmer, Kênia Cardoso Bícego, Luciane Helena Gargaglioni Batalhão · Alzheimer's & Dementia · 2025

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Alzheimer’s Disease
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In mice, the authors' cognition results showed that 7 days exposure to H₂ gas improved learning by 62% in time compared to STZ animals in room air. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. The authors' cognition results showed that 7 days exposure to H₂ gas improved learning by 62% in time compared to STZ animals in room air.

What the Researchers Studied

The researchers studied mice. The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

The animals were subsequently exposed to 2% hydrogen (H₂ ) for 5 ( n = 5) and 7 days ( n = 7). The authors' cognition results showed that 7 days exposure to H₂ gas improved learning by 62% in time compared to STZ animals in room air. The authors concluded that the dose of 3 mg/kg promotes cognitive and respiratory changes present in AD, thus becoming a dose for a model of sporadic Alzheimer's in the intermediate and late window of the disease. Thus, the researchers hypothesize that molecular hydrogen is a potential candidate for the prevention and treatment of AD since it is a gas with antioxidant, anti‐apoptotic and anti‐inflammatory effects.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.

Limitations and Safety

No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.